THE THROGMORTON TRUST PLC
All information is at 30 November 2012 and unaudited.
Performance at month end is calculated on a cum income basis
One Three One Three
Month Months Year Years
Net asset value 0.1% 6.3% 19.5% 74.1%
Share price 0.0% 6.2% 15.6% 79.2%
Numis plus AIM (ex Inv Cos) 0.2% 5.7% 16.5% 39.3%
Sources: BlackRock and Datastream
At month end
Net asset value capital only: 235.10p
Net asset value incl. income: 238.00p
Share price: 193.25p
Discount to cum income NAV 18.8%
Net yield: 1.6%*
Total assets: £174.4m**
Gross market exposure^: 104.8%
Ordinary shares in issue: 73,130,326***
*Calculated using current year interim and prior year final dividends paid.
**Includes current year revenue and excludes the gross exposure through
contracts for difference.
***Excluding 7,400,000 shares held in treasury.
^Long positions plus short positions as a percentage of net asset value.
Ten Largest Sector
Weightings % of total assets
Support Services 10.1
Software & Computer Services 7.9
Oil & Gas Producers 6.8
Financial Services 6.3
General Retailers 6.2
Electronic & Electrical Equipment 6.2
Chemicals 5.9
Travel & Leisure 5.5
Pharmaceuticals & Biotechnology 5.0
Media 5.0
----
Total 64.9
====
Market Exposure (Quarterly)
29.02.12 31.05.12 31.08.12 30.11.12
Long 119.8% 119.1% 116.1% 115.6%
Short 13.0% 12.8% 12.3% 10.8%
Gross exposure 132.8% 131.9% 128.4% 126.4%
Net exposure 106.8% 106.3% 103.8% 104.8%
Ten Largest Equity Investments (in alphabetical order)
Company
Ashtead
Aveva
AZ Electronic Materials
Bellway
Booker
Howden Joinery
Oxford Instruments
Senior
Victrex
Workspace
Commenting on the markets, Mike Prentis and Richard Plackett, representing the
Investment Manager noted:
During November the Company's NAV per share rose by 0.1% on a cum income basis
whilst the benchmark index rose by 0.2%. The FTSE 100 Index increased by 1.9%
(on a total return basis).
Sector allocation in the long only portfolio was slightly positive with our
overweight position in speciality chemicals companies contributing to relative
performance. Stock selection was marginally negative.
The CFD portfolio contributed well with gains being achieved on both the long
and the short CFDs during the month. We see this as quite significant and an
indication that in fairly flat markets the fundamental assessment we make of
companies can help to achieve profits on our gross risk position, not just on
our net CFD position.
No stock contributed more than 0.25% to relative performance in the long only
portfolio, positively or negatively. Our largest contributor to negative stock
selection in the month was from a smaller holding, Brainjuicer. Brainjuicer
warned profits would be below expectations because large corporate customers
had delayed spending on market research tools late in the year. Interestingly
sales of Brainjuicer's most innovative tools were up 39% in the 10 months to 31
October 2012 compared to the prior period, but other research tools revenues
were down 22% over the same period. The company has net cash and a strong
management team. We expect a better performance next year and therefore we are
retaining our holding.
We had good results, trading updates or meetings from/with various holdings
during the month including Oxford Instruments, Keller, Aveva, Hyder Consulting,
Big Yellow and Workspace.
There were no new holdings during the month. We continued to sell a number of
small holdings where we see limited near term upside.
14 December 2012
ENDS
Latest information is available by typing www.blackrock.co.uk/thrg on the
internet, "BLRKINDEX" on Reuters, "BLRK" on Bloomberg or "8800" on Topic 3 (ICV
terminal). Neither the contents of the Manager's website nor the contents of
any website accessible from hyperlinks on the Manager's website (or any other
website) is incorporated into, or forms part of, this announcement.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.